Mind + Muscle

technical minds + legal muscle


dig deep

Validity of Natural Products Patents Called into Question

  • 09.08.13
  • Gregory Glass
  • Asia IP

A recent article on United States Supreme Court decision in Association for Molecular Pathology v. Myriad Genetics quoted Sterne Kessler Director Robert W. Esmond, Ph.D. The article explains the Court's decision and how it will impact patents in the pharmaceuticals field. 

"This decision rendered invalid patent claims owned by Myriad Genetics as well as thousands of patent claims of others to such molecules," Dr. Esmond said. "There are going to be many more lawsuits because of the uncertainty of what is patentable."

Subscribers can read the full article here.

Related People

Related Industries

Sort By Media Type

Sort By Media Type
  • AlertAlert
  • BriefsBriefs
  • Comments to USPTOComments to USPTO
  • Design Patent Case DigestDesign Patent Case Digest
  • MultimediaMultimedia
  • News & ArticlesNews & Articles
  • Press ReleasePress Release
  • VideoVideo
  • WebinarWebinar

Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.L.L.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler.  If you are not already a client of Sterne Kessler, do not include any confidential information in this message.